AVNS - Avanos Medical, Inc.
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$23.00
DETAILS
HIGH:
$26.00
LOW:
$20.00
MEDIAN:
$23.00
CONSENSUS:
$23.00
DOWNSIDE:
6.54%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||
| Revenue | 701.2 | 687.8 | 673.3 | 684.1 | 744.6 | 714.8 | 697.6 | 652.3 | 611.6 | 566.2 | 1,574.4 | 1,672.1 | 1,677.5 | 1,684 | 1,659.9 |
| Cost of Revenue | 352.2 | 306.5 | 293.6 | 289.9 | 364.7 | 324.2 | 295.4 | 261.4 | 274.7 | 269 | 1,042.8 | 1,063.5 | 1,065.3 | 1,081.5 | 1,069.1 |
| Gross Profit | 349 | 381.3 | 379.7 | 394.2 | 379.9 | 390.6 | 402.2 | 390.9 | 336.9 | 297.2 | 531.6 | 608.6 | 612.2 | 602.5 | 590.8 |
| Operating Expenses | |||||||||||||||
| R&D Expenses | 23.1 | 26.2 | 27.2 | 30.6 | 32.3 | 34.9 | 37.7 | 41.8 | 38.2 | 38.4 | 32.3 | 33.6 | 37.9 | 33 | 31.2 |
| SG&A Expenses | 218.3 | 315.1 | 287.5 | 323.1 | 260.8 | 284.8 | 369.9 | 314.2 | 314.7 | 328.2 | 344.5 | 263.5 | 351.4 | 343 | 351.7 |
| Other Expenses | 169.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 410.6 | 341.3 | 314.7 | 352.3 | 293.1 | 319.7 | 407.6 | 356 | 352.9 | 366.6 | 376.8 | 297.1 | 389.3 | 376 | 382.9 |
| Operating Income | |||||||||||||||
| Operating Income | (61.6) | 40 | 65 | 41.9 | 86.8 | 70.9 | (5.4) | 34.9 | (16) | (69.4) | 154.8 | 311.5 | 222.9 | 226.5 | 207.9 |
| Interest Expense | 4 | 12.2 | 15 | 10 | 3.3 | 15.6 | 15 | 26.4 | 31.6 | 32.7 | 33.1 | 6 | 0.1 | 0.8 | 0.2 |
| Interest Income | 3.2 | 5.1 | 2.9 | 1.2 | 0.2 | 1.2 | 6.7 | 7.8 | 2.5 | 0.6 | 0.3 | 2.9 | 2.6 | 2.6 | 4.1 |
| Profitability | |||||||||||||||
| EBITDA | (33.2) | (345.6) | 50.6 | 77.8 | 48.9 | (2) | (12.1) | 37 | (0.6) | (65.5) | (311.4) | 182.2 | 297.1 | 288.2 | 265.9 |
| EBIT | (62.2) | (391.1) | 7.1 | 36.7 | 10.6 | (44.9) | (49) | 3.5 | (40.6) | (106.5) | (377.4) | 97.2 | 227.9 | 230.6 | 214.8 |
| Income Before Tax | (66.2) | (403.3) | (7.9) | 26.7 | 7.3 | (60.5) | (64) | (18.1) | (72.2) | (139.2) | (410.5) | 91.2 | 227.8 | 229.8 | 214.6 |
| Income Tax Expense | 1.7 | (17) | 2 | 5.2 | 1 | (33.3) | (18.1) | (9.6) | (40.1) | (55.9) | 15.8 | 64.1 | 73.2 | 77.2 | 72.2 |
| Net Income | (67.9) | (392.1) | (61.8) | 50.5 | 6.3 | (27.2) | (45.9) | 57.5 | 79.3 | 39.8 | (426.3) | 27.1 | 154.6 | 152.6 | 142.4 |
| Per Share Data | |||||||||||||||
| EPS (Basic) | -1.46 | -8.53 | -1.33 | 1.08 | 0.13 | -0.57 | -0.96 | 1.22 | 1.69 | 0.85 | -9.15 | 0.58 | 3.32 | 3.28 | 3.06 |
| EPS (Diluted) | -1.46 | -8.53 | -1.33 | 1.07 | 0.13 | -0.57 | -0.96 | 1.22 | 1.69 | 0.85 | -9.15 | 0.58 | 3.32 | 3.28 | 3.06 |
| Shares Outstanding | 46.4 | 46 | 46.6 | 46.9 | 48.1 | 47.8 | 47.6 | 47.2 | 46.5 | 46.6 | 46.6 | 46.5 | 46.5 | 46.5 | 46.5 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||
| Cash & Cash Equivalents | 89.8 | 107.7 | 87.7 | 127.7 | 118.5 | 111.5 | 205.3 | 384.5 | 219.7 | 113.7 |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 103.8 | 132.8 | 142.8 | 167.9 | 131.2 | 167.9 | 163.8 | 150.5 | 203 | 188.5 |
| Inventory | 148 | 138.8 | 163.2 | 132.3 | 159.3 | 168.9 | 145.9 | 121.4 | 91.1 | 272.5 |
| Other Current Assets | 13.8 | 14.1 | 93.3 | 196.2 | 0 | 0 | 0 | 57.2 | 632.5 | 194 |
| Total Current Assets | 355.4 | 393.4 | 487 | 624.1 | 427.6 | 467.2 | 538.5 | 713.6 | 1,160.7 | 593.5 |
| Non-Current Assets | ||||||||||
| Property, Plant & Equipment | 141 | 144.8 | 144 | 146.1 | 206.7 | 223.6 | 248.5 | 154.1 | 109.9 | 260.8 |
| Goodwill | 394.9 | 455.6 | 796.1 | 760.3 | 801.6 | 802.5 | 800.9 | 783.6 | 764.7 | 1,029 |
| Intangible Assets | 117.8 | 112.3 | 239.5 | 234.2 | 141.2 | 157.7 | 184.3 | 168.2 | 148.9 | 169.8 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 31.5 | 23.2 | 19.3 | 17.6 | 16.5 | 11.8 | 11.3 | 7.6 | 4.1 | 3.6 |
| Total Non-Current Assets | 718.3 | 760.8 | 1,205.4 | 1,162.8 | 1,176 | 1,205.6 | 1,261.1 | 1,119.8 | 1,035.2 | 1,478.3 |
| Total Assets | 1,073.7 | 1,154.2 | 1,692.4 | 1,786.9 | 1,603.6 | 1,672.8 | 1,799.6 | 1,833.4 | 2,195.9 | 2,071.8 |
| Current Liabilities | ||||||||||
| Account Payables | 55.5 | 54.3 | 56.3 | 67.9 | 56.4 | 67.6 | 83 | 169.9 | 171.2 | 160.6 |
| Short-Term Debt | 10.2 | 9.4 | 8.6 | 6.2 | 0 | 0 | 0 | 0 | 39.8 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 144.9 | 0 |
| Other Current Liabilities | 0 | 73.3 | 108.7 | 7.1 | 0 | 0 | 0 | 0 | 134.3 | 113.9 |
| Total Current Liabilities | 165.2 | 165.9 | 234.6 | 191 | 139.2 | 166.3 | 212.5 | 264.3 | 389.8 | 324.4 |
| Non-Current Liabilities | ||||||||||
| Long-Term Debt | 90.3 | 125.3 | 159.4 | 226.3 | 130 | 180 | 248.1 | 247.7 | 541.1 | 579 |
| Deferred Tax Liabilities | 6.1 | 5.5 | 23.8 | 25.4 | 11.9 | 5.7 | 0 | 4.4 | 17.8 | 35.8 |
| Other Non-Current Liabilities | 13.5 | 4.4 | 10 | 20.5 | 9.1 | 11 | 11.2 | 19.8 | 31.8 | 65.9 |
| Total Non-Current Liabilities | 130.3 | 159.8 | 221.5 | 304.7 | 193.8 | 250 | 321.9 | 271.9 | 590.7 | 644.9 |
| Total Liabilities | 295.5 | 325.7 | 456.1 | 495.7 | 333 | 416.3 | 534.4 | 536.2 | 980.5 | 969.3 |
| Stockholders' Equity | ||||||||||
| Common Stock | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 |
| Retained Earnings | (779.9) | (707) | (314.9) | (253.1) | (303.6) | (315.5) | (288.3) | (242.4) | (299.9) | (379.2) |
| Accumulated Other Comprehensive Income | (32) | (44.6) | (27) | (35.8) | (33.8) | (28.1) | (32) | (33.7) | (31.3) | (50.1) |
| Total Stockholders' Equity | 778.2 | 828.5 | 1,236.3 | 1,291.2 | 1,270.6 | 1,256.5 | 1,265.2 | 1,297.2 | 1,215.4 | 1,102.5 |
| Total Liabilities & Equity | 1,073.7 | 1,154.2 | 1,692.4 | 1,786.9 | 1,603.6 | 1,672.8 | 1,799.6 | 1,833.4 | 2,195.9 | 2,071.8 |
| Debt Metrics | ||||||||||
| Total Debt | 129.1 | 170.2 | 209.1 | 277 | 187.5 | 248.8 | 325.4 | 247.7 | 580.9 | 579 |
| Net Debt | 39.3 | 62.5 | 121.4 | 149.3 | 69 | 137.3 | 120.1 | (136.8) | 361.2 | 465.3 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Net Income | (72.9) | (392.1) | (61.8) | 50.5 | 5.2 | (27.2) | (45.9) | 57.5 | 79.3 | 39.8 |
| Depreciation & Amortization | 38.9 | 45.5 | 46.1 | 47.7 | 38.3 | 42.9 | 36.9 | 33.5 | 59.5 | 65.2 |
| Stock-Based Compensation | 0 | 13.8 | 15.8 | 15.9 | 13.2 | 12.1 | 10.5 | 10.5 | 12.6 | 14.8 |
| Change in Working Capital | 9.8 | 35 | (18) | (24.3) | 26 | (67.8) | (59.6) | (143.4) | (4.3) | 91.6 |
| Other Non-Cash Items | 98.9 | 398.5 | 50.3 | 1.1 | 8 | 11.6 | (9.9) | (107.4) | 3.3 | (11.1) |
| Operating Cash Flow | 74.7 | 100.7 | 32.4 | 90.9 | 87.3 | (2.5) | (74.5) | (145.6) | 144.2 | 188.8 |
| Investing Activities | ||||||||||
| Capital Expenditure | (31.6) | (17.8) | (17.8) | (19.3) | (21) | (20.2) | (50.6) | (49.1) | (43.2) | (29.1) |
| Acquisitions | (28) | (9.7) | 39.4 | (116.1) | 0 | (4) | (57.5) | 688.6 | 0.1 | (175) |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales/Maturities of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (1) | 0 | 0 | 0 | 0 | 0 | 0 | 754.3 | 0.1 | 3.2 |
| Investing Cash Flow | (60.6) | (27.5) | 21.6 | (135.4) | (21) | (24.2) | (108.1) | 639.5 | (43.1) | (200.9) |
| Financing Activities | ||||||||||
| Net Debt Issuance | (34.4) | (33.6) | (64.7) | 103.4 | (50) | (69.8) | (0.2) | (339) | 0 | (0.9) |
| Stock Repurchased | (3.3) | (12.8) | (19.1) | (45.5) | (11.5) | (0.9) | (3.6) | (0.9) | (2.5) | (0.9) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | (2.7) | (10.4) | (1.2) | 6.2 | 0.7 | 5.3 | 15.5 | 4.7 | 0.4 |
| Financing Cash Flow | (37) | (49.1) | (94.2) | 56.7 | (55.3) | (70) | 1.5 | (324.4) | 2.2 | (1.4) |
| Cash Position | ||||||||||
| Net Change in Cash | (17.9) | 20 | (40) | 9.2 | 7 | (93.8) | (179.2) | 164.8 | 106 | (15.8) |
| Cash at Beginning | 107.7 | 87.7 | 127.7 | 118.5 | 111.5 | 205.3 | 384.5 | 219.7 | 113.7 | 129.5 |
| Cash at End | 89.8 | 107.7 | 87.7 | 127.7 | 118.5 | 111.5 | 205.3 | 384.5 | 219.7 | 113.7 |
| Free Cash Flow | 43.1 | 82.9 | 14.6 | 71.6 | 66.3 | (22.7) | (125.1) | (194.7) | 101 | 159.7 |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||||
| Revenue | 701.2 | 687.8 | 673.3 | 684.1 | 744.6 | 714.8 | 697.6 | 652.3 | 611.6 | 566.2 | 1,574.4 | 1,672.1 | 1,677.5 | 1,684 | 1,659.9 |
| Gross Profit | 349 | 381.3 | 379.7 | 394.2 | 379.9 | 390.6 | 402.2 | 390.9 | 336.9 | 297.2 | 531.6 | 608.6 | 612.2 | 602.5 | 590.8 |
| Operating Income | (61.6) | 40 | 65 | 41.9 | 86.8 | 70.9 | (5.4) | 34.9 | (16) | (69.4) | 154.8 | 311.5 | 222.9 | 226.5 | 207.9 |
| Net Income | (67.9) | (392.1) | (61.8) | 50.5 | 6.3 | (27.2) | (45.9) | 57.5 | 79.3 | 39.8 | (426.3) | 27.1 | 154.6 | 152.6 | 142.4 |
| EPS (Diluted) | -1.46 | -8.53 | -1.33 | 1.07 | 0.13 | -0.57 | -0.96 | 1.22 | 1.69 | 0.85 | -9.15 | 0.58 | 3.32 | 3.28 | 3.06 |
| Balance Sheet | |||||||||||||||
| Cash & Equivalents | 89.8 | 107.7 | 87.7 | 127.7 | 118.5 | 111.5 | 205.3 | 384.5 | 219.7 | 113.7 | |||||
| Total Assets | 1,073.7 | 1,154.2 | 1,692.4 | 1,786.9 | 1,603.6 | 1,672.8 | 1,799.6 | 1,833.4 | 2,195.9 | 2,071.8 | |||||
| Total Debt | 129.1 | 170.2 | 209.1 | 277 | 187.5 | 248.8 | 325.4 | 247.7 | 580.9 | 579 | |||||
| Stockholders' Equity | 778.2 | 828.5 | 1,236.3 | 1,291.2 | 1,270.6 | 1,256.5 | 1,265.2 | 1,297.2 | 1,215.4 | 1,102.5 | |||||
| Cash Flow | |||||||||||||||
| Operating Cash Flow | 74.7 | 100.7 | 32.4 | 90.9 | 87.3 | (2.5) | (74.5) | (145.6) | 144.2 | 188.8 | |||||
| Capital Expenditure | (31.6) | (17.8) | (17.8) | (19.3) | (21) | (20.2) | (50.6) | (49.1) | (43.2) | (29.1) | |||||
| Free Cash Flow | 43.1 | 82.9 | 14.6 | 71.6 | 66.3 | (22.7) | (125.1) | (194.7) | 101 | 159.7 | |||||